Back

The current role of Dronedarone.

20 June 2017 (11:00 - 11:22)
Organised by:
Congress Presentation Part of: Pharmacological therapy in AF Pharmacology EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

3 More presentations in this session

Presentation thumbnail
Ranolazine – mechanism and clinical results in AF.
Professor G. De Ferrari (Turin, IT)
Slides Video
Presentation thumbnail
Atrial-specific antiarrhythmic agents.
Doctor S. Nattel (Montreal, CA)
Slides Video
Presentation thumbnail
Non anti arrhythmic pharmacological therapy for maintenance of sinus rhythm.
Doctor I. Savelieva (London, GB)
Slides Video

Access the full session

Session thumbnail
Pharmacological therapy in AF

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials
1 September 2019
thumbnail
Webinar
Current role of cardiovascular pharmacotherapy for arrhythmia management
9 December 2021
thumbnail
Congress Presentation
Efficacy of bepridil as a periprocedural support drug in atrial fibrillation patients with left ventricular systolic dysfunction undergoing catheter ablation
26 August 2023
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources